| NCT Number | NCT07748702 |
| Lead Sponsor | Chong Kun Dang Pharmaceutical |
| Conditions | Hypertension |
| Enrollment | 76 participants |
| Start Date | 2026-08-20 |
| Primary Completion | 2026-10-06 (estimated) |
| Study Completion | 2026-10-12 (estimated) |
| Updated on ClinicalTrials.gov | 2026-08-06 |